Call for Nominations to AUA’s Measure Evaluation Panel
The American Urological Association (AUA) is committed to helping our members improve the quality of care they provide to their patients. In 2019, the AUA formed the Measures Evaluation Panel (MEP), which operates under the direction of the Quality Improvement and Patient Safety (QIPS) Committee. The MEP provides input and assistance in the maintenance and testing of current AUA measures, as well as guidance for future measure development efforts. To respond to evolving technical, programmatic, and implementation issues related to the performance measurement enterprise, the AUA has decided to broaden the expertise and perspectives provided by the MEP by adding 5-8 new members. We are seeking physician or non-physician nominees with experience and/or expertise in the following:
- Clinical expertise in female pelvic medicine and reconstructive surgery
- Primary care expertise
- Private practice experience (solo, small group, or large group)
- Payer, purchaser, and/or health system perspective
- Patient perspective: previous or current urologic condition
- Measurement and/or improvement science
Nominees with subject matter expertise in more than one of the above areas will be given preference in the selection process. The AUA will endeavor to ensure representation from a variety of stakeholder backgrounds and perspectives.
See the MEP Call for Nominations for additional information on expectations and instructions on how to apply.
The deadline for all nominations is 6:00pm ET on Wednesday, June 30, 2021.
A team of dedicated physician volunteers comprises the Quality Improvement and Patient Safety (QIPS) Committee, which reports to the Science & Quality Council. Along with the AUA’s Quality Department, QIPS members are responsible for establishing the AUA's quality and patient safety agenda and determining new initiatives.
The AUA is actively engaged in many quality initiatives and has emerged as a leading player in this arena. The AUA has physician and professional staff representatives on every major national decision-making body and has been instrumental in the formulation of urology-specific measures. The AQUA Registry includes measures on prostate cancer, BPH, female urology, stones, bladder cancer and other key urologic conditions. Additionally, the AUA collaborates with organizations and specialty societies to develop cross-cutting measures of interest to urologists and other health care providers.
The QIPS Committee also guides the AUA’s efforts on quality improvement, convening QI Summits on important quality and patient safety issues facing urology and other specialties. QIPS also provides patient safety education and develops urology-specific statements for Choosing Wisely. Furthermore, QIPS develops white papers on emerging quality and patient safety topics.